Angiogenesis is an important process, which sustains ovarian cancer growth. Cediranib, a potent, oral tyrosine kinase inhibitor (TKI) of vascular endothelial growth factor receptor (VEGFR) 1, 2, and 3, and c-kit, has shown promise in other solid tumors, including non-small cell lung cancer.
In this issue: Statin and niacin increase HDL-C, omeprazole reduces effectiveness of clopidogrel, darbe-poetin increases risk of stroke, statins decrease risk of gallstone disease, FDA Actions.
Based on results of two systematic evidence reviews, the USPSTF issued a revised statement regarding recommendations for breast cancer screening.
Three to 5% of patients at term will have breech presentations, and in most countries 90% of these patients will be delivered by Cesarean section.
This statement from the practice committee of the American Society for Reproductive Medicine provides an update to what is known about pelvic adhesions and gynecologic surgery.
